Answers are grounded in this paper and cite their sources.
When the primary outcome of a clinical trial fails to reach its prespecified end point, can any clinically meaningful information still be derived from it? This review article addresses that question.
No takes yet. Share an insight, caveat, or question.
Pocock et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: